October 5, 2023 | 12:00pm ET / 9:00am PT | Hosted by Oxford Global
SPECIAL OFFER: Attending this webinar automatically enters you to win a FREE PLUS Pass from Oxford Global valued at $1,350!
Autoimmune diseases present with a wide range of clinical symptoms, severity, and therapeutic response, complicating the diagnosis and treatment of patients. Small molecule biomarkers read out dynamic changes that occur with immune system activation, dysregulation, and response to drug exposure. In this webinar, we will discuss how high throughput mass spectrometry-based methods can be applied to broadly assay thousands of metabolites and lipids per sample at a time, to read out early and subtle changes in immune cell populations, their activation and function, and dynamic response in the setting of autoimmune disease and treatment.
You will learn:
- Why discovery of dynamic small molecule biomarkers in the setting of autoimmunity can drive greater understanding of disease mechanisms and subtypes, patient response, and drug safety
- How emerging technologies are now enabling rapid measure of dynamic small molecule biomarkers at population level scale
- How integration of small molecule biomarkers with other dynamic readouts, including cytokine measures, can inform development of safer, more efficacious treatments that target the underlying pathways of autoimmune diseases
Click here to register now!
Dynamic Biomarkers for Deep Immune Phenotyping in Autoimmune Disease
October 5, 2023 | 12:00pm ET / 9:00am PT | Hosted by Oxford Global REGISTER NOW SPECIAL OFFER: Attending this webinar automatically enters you to win a FREE PLUS Pass… Read More
Nature Webinar | Beyond the genome: small-molecule biomarkers drive new advances in drug discovery
Now On Demand | Hosted by Nature Research WATCH NOW Human disease is a highly dynamic process. While next-generation genomic sequencing has provided enormous insight into the genetic underpinnings of human health and disease, dynamic measures that integrate changes… Read More
Timing is Everything: Biomarkers for Early Detection of Preclinical Toxicology Events
Now On Demand | Hosted by AAPS Small molecule biomarkers represent dynamic indicators of adverse effects in the setting of drug exposure and can provide an early warning of drug toxicity prior to histopathological changes. Nontargeted measurement of small molecule biomarkers in preclinical samples can lead… Read More
High-Throughput Biomarker Discovery for Clinical Trial Optimization
Now On Demand | Hosted by Oxford Global Advances in mass spectrometry resolution and sensitivity have enabled increasingly comprehensive views into the multitude of small molecule metabolites circulating in humans. These metabolites read out diverse host and environmental exposures that influence human health and may serve as… Read More
The Clinical Trial Conundrum: Identifying Responders vs. Non-Responders
Now On Demand | Hosted by AAPS Will a patient respond or not respond to the given therapy? That is the fundamental question for any clinical trial – and not an easy answer to predict. Patients are unique; diseases are dynamic and represent heterogeneous biology, collectively… Read More
Fierce Webinar: Population-Scale Circulating Biomarker Discovery to Accelerate Drug Development
Now On Demand | Hosted by Fierce Pharma WATCH NOW In this session, Sapient discusses application of its next-generation mass spectrometry approaches for large-scale biomarker discovery across diverse human diseases, enabling measure of tens of thousands of small… Read More
What’s Next in Precision Medicine? Small Molecule Biomarkers to Personalize Disease Prediction, Diagnostics and Therapies
Now On Demand | Hosted by AAPS WATCH NOW While next-generation sequencing has been instrumental in advancing genomics-based precision medicine, the full potential of personalized therapy has yet to be realized at scale. DNA biomarkers help identify genetic… Read More
Mapping the Missing Link: Bridging the Gap Between Human Genetics and Disease Biology Through Small Molecule Biomarker Discovery
Now On Demand | Hosted by AAPS WATCH NOW Genome-wide association studies (GWAS) have been transformative in elucidating the genetic landscape of human disease, defining hundreds of common and rare genetic variants that contribute to the development… Read More
Identifying Non-Invasive Biomarkers of Target Engagement
Now On Demand | Hosted by AAPS WATCH NOW A key aspect of the drug discovery pipeline is evaluation of in vivo target engagement and subsequent biological response. While measures of target engagement are often optimized in cellular… Read More
Smaller, Faster & More Effective: Clinical Trial Enrichment Using Circulating Biomarkers
Now On Demand | Hosted by AAPS WATCH NOW Diseases are singularly defined but often represent varied groupings of contributing factors and pathways that ultimately produce a shared pathology. Heterogeneous molecular pathogenesis creates heterogeneity in treatment responsiveness, which… Read More
